Idilman, R. Et Al. 2012. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients. JOURNAL OF VIRAL HEPATITIS , vol.19, no.3 , 220-226.

Idilman, R., Cinar, K., Seven, G., Bozkus, Y., ELHAN, A. H., Bozdayi, M., ... Yurdaydin, C.(2012). Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients. JOURNAL OF VIRAL HEPATITIS , vol.19, no.3, 220-226.

Idilman, RAMAZAN Et Al. "Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients," JOURNAL OF VIRAL HEPATITIS , vol.19, no.3, 220-226, 2012

Idilman, RAMAZAN Et Al. "Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients." JOURNAL OF VIRAL HEPATITIS , vol.19, no.3, pp.220-226, 2012

Idilman, R. Et Al. (2012) . "Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients." JOURNAL OF VIRAL HEPATITIS , vol.19, no.3, pp.220-226.

@article{article, author={RAMAZAN İDİLMAN Et Al. }, title={Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients}, journal={JOURNAL OF VIRAL HEPATITIS}, year=2012, pages={220-226} }